News
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...
These insights help researchers fine-tune biopharmaceutical processes, reducing development timelines and increasing the likelihood of regulatory approval. Regulatory compliance is another area where ...
The biopharmaceutical landscape stands at ... and expedite the overall gene therapy development timeline. Accelerating pre-clinical gene target discovery The overwhelming volume of large-scale ...
US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...
GC Biopharma has partnered with Körber to implement a large-scale Manufacturing Execution System (MES) project across ...
The Company has built a highly experienced management team with specific experience in biopharmaceutical and botulinum toxin development and commercialization.
Accelerated Delivery Timelines - Over One Month ... from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise ...
a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results